Roivant Sciences Ltd. - Common Shares (ROIV)

CUSIP: G76279101

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 7 signals
Share change
+47,566,007
Put/Call ratio
20%
SEC-reported price per share
$7.38
Number of holders
144
Value change
+$349,480,110
Number of buys
106
Open additional details 1 more signal available
Number of sells
30
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
717,012,101

Security key

G76279101

Report period

Q1 2023

Institutions

144

Top holders

10

Ownership snapshot

Top reported holders of ROIV - Roivant Sciences Ltd. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
QVT Financial LP
Disclosed value leader
QVT Financial LP
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F Lead comparable stake: 17% Showing 1-6 of 15 holder rows.

Quick read

QVT Financial LP leads the comparable SEC ownership view at 17%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens QVT Financial LP's linked filing trail.
Comparable ownership Top 5
QVT Financial LP 17%
SB INVESTMENT ADVISERS (UK) LTD 13%
VIKING GLOBAL INVESTORS LP 12%
FMR LLC 4.2%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
QVT Financial LP
13F
Company
13F
17%
$979,106,873
122,541,536 shares
31 Dec 2022
SB INVESTMENT ADVISERS (UK) LTD
13F
Company
13F
13%
$759,303,019
95,031,667 shares
31 Dec 2022
VIKING GLOBAL INVESTORS LP
13F
Company
13F
12%
$705,027,213
88,238,700 shares
31 Dec 2022
FMR LLC
13F
Company
13F
4.2%
$242,668,205
30,371,490 shares
31 Dec 2022
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
1.3%
$71,897,528
8,998,439 shares
31 Dec 2022
Patient Square Capital LP
13F
Company
13F
0.95%
$54,539,476
6,825,967 shares
31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
144
Shares
459,356,125
Rows available
144
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders
144
Q1 2023 holders
144
Holder diff
0
Investor Q1 2023 Shares Q1 2023 Shares Share Diff Share Chg % Q1 2023 value Q1 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .